NRSNW
NeuroSense Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.05
−8.16%Institutional positioning
13F filings over the trailing two quarters
New 0Increased 0Reduced 1Sold out 0
| Filer | Action | Shares | Filed |
|---|---|---|---|
| EMPERY ASSET MANAGEMENT, LP | Unchanged | 100,402 | May 8, 2026 |
| Empery Asset Management, LP | Unchanged | 100,402 | Aug 11, 2026 |
| CLEAR STREET GROUP INC. | Unchanged | 63,385 | May 15, 2026 |
| Clear Street Group Inc. | Reduced | 63,085 | Aug 12, 2026 |
| UBS Group AG | Unchanged | 1,163 | Aug 13, 2026 |
| UBS GROUP AG | Unchanged | 1,163 | May 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings